CLINICAL_TRIALS
trial_result
· 2012-02-13
Clinical Trial Update: Rituximab in Addition to Autologous Transplantation With BEAM for Patients With Lymphoid Malignancies [Phase 2]
Summary
Phase 2 trial evaluating rituximab added to BEAM-conditioned autologous stem cell transplantation for lymphoid malignancies. Results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: M.D. Anderson Cancer Center | Conditions: Lymphoma | Phase 2 | Status: COMPLETED | Results posted: 2012-02-13